Meeting
2018 Genitourinary Cancers Symposium
A biopsy-based genomic classifier to predict biochemical failure after definitive radiation without hormone therapy in a prospective cohort of intermediate risk prostate cancer.
Authors
Melvin Chua
National Cancer Centre Singapore, Singapore, Singapore
Melvin Chua , Jure Murgic , Ali Hosni , Adriana Salcedo , Suzanne Kamel-Reid , Alejandro Berlin , Melania Pintile , Michael Fraser , Theodorus Van Der Kwast , Paul Christopher Boutros , Robert G. Bristow
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 68)
DOI
10.1200/JCO.2018.36.6_suppl.68
Abstract #
68
Poster Bd #
D10
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Combinatorial genomic and pathological indices for integrated stratification of unfavorable intermediate-risk prostate cancer.
First Author: Melvin Chua
Poster
2016 Genitourinary Cancers Symposium
Genomic predictors of biochemical failure following radical prostatectomy.
First Author: Sanjay Aneja
Poster
2016 Genitourinary Cancers Symposium
Prognostic value of copy-number alterations of the Cohesin complex in intermediate-risk prostate cancer recurrence.
First Author: Jonathan So
Poster
2016 Genitourinary Cancers Symposium
Copy number alterations of P53, RB1, and MDM2 as prognostic markers in intermediate-risk prostate cancer.
First Author: Osman Mahamud